Document Detail


Iron in sickle-cell disease: what have we learned over the years?
MedLine Citation:
PMID:  21157888     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Over the last four decades, monumental advances have been made in the understanding, assessment, and management of transfusion-dependent patients, which have translated into significant improvements in patient morbidity and mortality. Important lessons have been learned from extensive clinical experience of iron management in the thalassemias, but greater knowledge of key differences in the sickle-cell disease (SCD) population may impact on our approach to patient assessment and management. The unique pathophysiology of SCD is reflected in a distinct pattern of iron loading with minimal organ-specific injury. An appreciation and understanding of these differences should allow us to develop tailored management approaches that optimize patient outcomes.
Authors:
Adlette Inati; Evelyne Khoriaty; Khaled M Musallam
Related Documents :
3277318 - Mutagenicity of monochlorodibenzofurans detected in the environment.
20124958 - Creating an organizational model to support advanced practice.
19074048 - Transitioning from fellowship to a physician-scientist career track.
16097848 - Erotomania : epidemiology and management.
9684418 - Tackling warts on the hands and feet.
21782968 - Anglo-saxon pharmacopoeia revisited: a potential treasure in drug discovery.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2010-11-08
Journal Detail:
Title:  Pediatric blood & cancer     Volume:  56     ISSN:  1545-5017     ISO Abbreviation:  Pediatr Blood Cancer     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2010-12-15     Completed Date:  2011-01-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101186624     Medline TA:  Pediatr Blood Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  182-90     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Wiley-Liss, Inc.
Affiliation:
Division of Paediatric Haematology and Oncology, Children's Centre for Cancer and Blood Diseases, Rafik Hariri University Hospital, Beirut, Lebanon. adlette.inati@lau.edu.lb
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anemia, Sickle Cell / metabolism,  therapy*
Blood Transfusion / adverse effects*
Humans
Iron / metabolism*
Iron Overload / etiology*,  metabolism
Chemical
Reg. No./Substance:
7439-89-6/Iron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence of multiple congenital contractures including arthrogryposis multiplex congenita in Alber...
Next Document:  Bone mineral density in newly diagnosed children with neuroblastoma.